Pneumococcal conjugate second or third-dose vaccines (PCVc) in Antigua and Barbuda
Antigua and Barbuda: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 0.0% in 2025. ▬ Flat
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Antigua and Barbuda, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Antigua and Barbuda is 0.0%, measured in 2025. That is the highest value across all 18 years on record.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Antigua and Barbuda peaked at 0.0% in 2008 and was at its lowest, 0.0%, in 2008.
That places Antigua and Barbuda 165th out of 192 countries with data for 2025, putting it in the bottom quarter.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 0.0% | 0.0% | 0.0% | 6 |
Countries ranked near Antigua and Barbuda
- 162 Somalia 20.0% compare
- 163 Belarus 16.0% compare
- 164 Maldives 2.0% compare
- 165 Egypt 0.0% compare
- 165 Czechia 0.0% compare
- 165 Estonia 0.0% compare
- 165 Austria 0.0% compare
- 165 Vietnam 0.0% compare
- 165 Monaco 0.0% compare
- 165 Ukraine 0.0% compare
- 165 Saint Vincent and the Grenadines 0.0% compare
- 165 North Korea 0.0% compare
- 165 Guinea 0.0% compare
- 165 Sri Lanka 0.0% compare
- 165 Jordan 0.0% compare
- 165 Saint Lucia 0.0% compare
- 165 Gabon 0.0% compare
- 165 Grenada 0.0% compare
- 165 China (People’s Republic of) 0.0% compare
- 165 Comoros 0.0% compare
- 165 Cape Verde 0.0% compare
- 165 Syria 0.0% compare
- 165 Jamaica 0.0% compare
- 165 Venezuela 0.0% compare
- 165 Equatorial Guinea 0.0% compare
- 165 Thailand 0.0% compare
- 165 Dominica 0.0% compare
- 165 Brunei 0.0% compare
- 165 Bosnia and Herzegovina 0.0% compare
- 165 Saint Kitts and Nevis 0.0% compare
More health data for Antigua and Barbuda
- Heat deaths vs projected death rates, annual growth rate 0.0772 % change on previous year (2090)
- Heat deaths vs projected death rates 1,555 (2090)
- Un projection of annual infant deaths 1 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 704 (2025)
- Age population, age 25, female, interpolated 690 (2025)
- Age population, age 24, male, interpolated 714 (2025)
- Age population, age 24, female, interpolated 698 (2025)
- Age population, age 23, male, interpolated 672 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Antigua and Barbuda?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Antigua and Barbuda was 0.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Antigua and Barbuda?
- The highest recorded value was 0.0% in 2008.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Antigua and Barbuda?
- The lowest recorded value was 0.0% in 2008.
- How does Antigua and Barbuda rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Antigua and Barbuda ranks 165th out of 192 countries with data for 2025.
- Where does this Antigua and Barbuda data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).